Literature DB >> 11393191

Microbial modulation of innate defense: goblet cells and the intestinal mucus layer.

B Deplancke1, H R Gaskins.   

Abstract

The gastrointestinal epithelium is covered by a protective mucus gel composed predominantly of mucin glycoproteins that are synthesized and secreted by goblet cells. Changes in goblet cell functions and in the chemical composition of intestinal mucus are detected in response to a broad range of luminal insults, including alterations of the normal microbiota. However, the regulatory networks that mediate goblet cell responses to intestinal insults are poorly defined. The present review summarizes the results of developmental, gnotobiotic, and in vitro studies that showed alterations in mucin gene expression, mucus composition, or mucus secretion in response to intestinal microbes or host-derived inflammatory mediators. The dynamic nature of the mucus layer is shown. Available data indicate that intestinal microbes may affect goblet cell dynamics and the mucus layer directly via the local release of bioactive factors or indirectly via activation of host immune cells. A precise definition of the regulatory networks that interface with goblet cells may have broad biomedical applications because mucus alterations appear to characterize most diseases of mucosal tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393191     DOI: 10.1093/ajcn/73.6.1131S

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  233 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

2.  Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice.

Authors:  Saul Rojas-Hernández; Adriana Jarillo-Luna; Marco Rodríguez-Monroy; Leticia Moreno-Fierros; Rafael Campos-Rodríguez
Journal:  Parasitol Res       Date:  2004-07-29       Impact factor: 2.289

Review 3.  Diversity and function of the avian gut microbiota.

Authors:  Kevin D Kohl
Journal:  J Comp Physiol B       Date:  2012-01-14       Impact factor: 2.200

Review 4.  Host-bacterial symbiosis in health and disease.

Authors:  Janet Chow; S Melanie Lee; Yue Shen; Arya Khosravi; Sarkis K Mazmanian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 5.  Surveillance B lymphocytes and mucosal immunoregulation.

Authors:  Peter Velázquez; Bo Wei; Jonathan Braun
Journal:  Springer Semin Immunopathol       Date:  2004-12-18

6.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

7.  Opioid use potentiates the virulence of hospital-acquired infection, increases systemic bacterial dissemination and exacerbates gut dysbiosis in a murine model of Citrobacter rodentium infection.

Authors:  Fuyuan Wang; Jingjing Meng; Li Zhang; Sabita Roy
Journal:  Gut Microbes       Date:  2019-08-05

8.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Sulfation of colonic mucins by N-acetylglucosamine 6-O-sulfotransferase-2 and its protective function in experimental colitis in mice.

Authors:  Yuki Tobisawa; Yasuyuki Imai; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

10.  Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.

Authors:  Oxana Norkina; Tim G Burnett; Robert C De Lisle
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.